How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
36
OCX Quote, Financials, Valuation and Earnings
Last price:
$3.00
Seasonality move
:
-2.87%
Day range:
$2.99 - $3.52
52-week range:
$1.92 - $4.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
21.25x
P/B ratio:
5.77x
Volume:
68.6K
Avg. volume:
97.9K
1-year change:
4.44%
Market cap:
$87.5M
Revenue:
$1.9M
EPS (TTM):
-$4.40
Earnings Data
Next earnings date for OCX
May 15
2025
Most recent earnings per share
-$1.93
Missed by $1.93
(Mar 24/2025)
Consensus Estimate
--
(Mar 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
OCX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $154.5K | -- | -- | -$0.24 | -- |
| 05/15/2025 | Q1 | $126.8K | -- | -- | -$0.25 | -- |
| 03/24/2025 | Q4 | $101.7K | $1.5M | -$1.93 | -- | -- |
| 11/12/2024 | Q3 | $168.3K | $115K | -$0.98 | -- | -- |
| 08/08/2024 | Q2 | $312.4K | $104K | -$0.36 | -$0.37 | $0.01 |
| 05/15/2024 | Q1 | $350K | $176K | -$1.13 | -$0.57 | -$0.56 |
| 03/29/2024 | Q4 | $316.7K | $314K | -$2.07 | -- | -- |
| 11/09/2023 | Q3 | $312.5K | $429K | -$0.81 | -$0.78 | -$0.03 |
| 08/10/2023 | Q2 | $350K | $463K | -$1.07 | -$0.59 | -$0.48 |
| 05/11/2023 | Q1 | $336.4K | $297K | $0.40 | -$1.30 | $1.70 |
| 03/31/2023 | Q4 | $1.4M | $274K | -$8.03 | -$1.60 | -$6.43 |
| 11/10/2022 | Q3 | $1.5M | $67K | -$1.62 | -$2.33 | $0.71 |
| 08/10/2022 | Q2 | -- | $237K | -$1.48 | -- | -- |
| 05/11/2022 | Q1 | -- | $380K | -$2.20 | -- | -- |
| 03/10/2022 | Q4 | -- | -$1.9M | -$7.80 | -- | -- |
| 11/09/2021 | Q3 | -- | $984K | -$3.00 | -- | -- |
| 08/10/2021 | Q2 | -- | $2M | -$2.40 | -- | -- |
| 05/17/2021 | Q1 | -- | $1.1M | -$1.00 | -- | -- |
| 03/16/2021 | Q4 | -- | $503K | -$1.80 | -- | -- |
| 11/12/2020 | Q3 | -- | $555K | -$2.00 | -- | -- |
| 07/29/2020 | Q2 | -- | $143K | -$2.80 | -- | -- |
| 05/12/2020 | Q1 | -- | $16K | -$2.60 | -- | -- |
| 03/25/2020 | Q4 | -- | -- | -$3.00 | -- | -- |
| 11/14/2019 | Q3 | -- | -- | -$2.00 | -- | -- |
| 08/14/2019 | Q2 | -- | -- | -$2.07 | -- | -- |
| 04/01/2019 | Q1 | -- | -- | -$1.60 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$2.20 | -- | -- |
| 11/13/2018 | Q3 | -- | -- | -$1.40 | -- | -- |
| 08/14/2018 | Q2 | -- | -- | -$2.40 | -- | -- |
| 04/02/2018 | Q1 | -- | -- | -$2.40 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$2.60 | -- | -- |
| 11/14/2017 | Q3 | -- | -- | -$4.40 | -- | -- |
| 08/14/2017 | Q2 | -- | -- | -$2.60 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$3.20 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$2.20 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$2.00 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$2.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$2.40 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$2.80 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$1.90 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$4.35 | -- | -- |
OncoCyte Earnings Questions
-
How Much did OncoCyte Generate in Revenue Last Quarter?
OncoCyte reported $1.5M worth of top line sales in its most recent quarter.
-
Did OncoCyte Beat Earnings Last Quarter?
OncoCyte announced earnings per share of -$1.93 which represents a miss of analyst forecast a -- per share.
-
Is OncoCyte Profitable?
OncoCyte reported $595K that represents $0.03 per share over the last quarter.
-
What is the Analyst Consensus for OncoCyte EPS Next Year?
OncoCyte's earnings are forecast to decrease from -$4.66 per share to -$0.97 per share next year representing a decrease of -79.19%.
-
When is OncoCyte's Earnings Date?
OncoCyte's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
